Spurred by advances in energy-harvesting materials, a new generation of advanced implantable biomedical devices is emerging that does away with the bulky battery. James Mitchell Crow reports
When Swedish doctors performed the first fully implantable cardiac pacemaker surgery in 1958, the device they had invented was powered by a rechargeable nickel–cadmium battery, connected to a wire coil that enabled magnetic induction wireless recharging across the skin. The battery, coil and controlling electronics were housed in a shoe-polish-sized can implanted in the abdomen, with leads running to the heart to deliver the pulsed electrical stimulus.
Millions of people with a slow or irregular heartbeat have since benefited from a pacemaker implant – which soon evolved to use longer-lasting batteries that were replaced surgically every few years, rather than requiring a weekly recharge. More than six decades later, however, the basic pacemaker design – a remotely located can containing the bulky battery pack and electronics, connected to the heart by long leads – remains unchanged.
As bioelectronics has advanced, experimental implants have been demonstrated that enable people with severe spinal cord injuries to walk again, or people who have lost a limb to control and experience a sense of touch from a robotic prosthetic. To turn these experimental prototypes into practical devices that could be implanted at target sites around the body, developing miniaturised all-in-one implants could be key. The limitation on miniaturisation is not the electronics, but the power available after shrinking the battery.